Erasca, Inc. (ERAS): A Theory of the Bull Case
We found a bullish thesis on Erasca, Inc. on Danny’s Substack by Danny Green. In this article we will summarize the bulls’ thesis on ERAS. Erasca, Inc. stock was trading at $12.39 on February 19. Cidara (CDTX) rises 105% after a $9.2 billion merger with Merck Photo from the National Cancer Institute on Unsplash Erasca,…